首页> 外国专利> MULTIMERIC TETHERED LIGANDS AND THEIR USE IN RECEPTOR-LIGAND INTERACTIONS

MULTIMERIC TETHERED LIGANDS AND THEIR USE IN RECEPTOR-LIGAND INTERACTIONS

机译:聚四氟乙烯配体及其在受体-配体相互作用中的用途

摘要

Multimeric tethered ligands are disclosed, comprising a plurality of ligand moieties tethered to a joint moiety, wherein each ligand moiety comprises a ligand for at least one receptor protein having multiple binding sites for the ligand and each ligand moiety is linked by a tether moiety to that joint moiety. Exemplary dimeric tethered ligands are disclosed in which the tether is a simple polymer, polyethylene glycol, which are therefore called "polymer-linked dimers" (PLDs). Exemplary PLDs containing two guanosine 3', 5' cyclic monophosphate (cGMP) moieties are described which are up to 1,000-fold more potent than cGMP in activating cyclic nucleotide-gated (CNG) channels and protein kinases. Each protein responds optimally to a PLD with a different average polymer length, indicating that each has a unique spacing of binding sites. Since optimal ligands are selected empirically, the multivalent tethered ligand strategy allows identification of highly potent and specific agents with no prior structural information about target proteins.
机译:公开了多聚体拴系的配体,其包含拴系在关节部分上的多个配体部分,其中每个配体部分包括至少一个具有多个配体结合位点的受体蛋白的配体,并且每个配体部分通过系链部分连接到该配体上。关节部分。公开了示例性的二聚体系链配体,其中该系链是简单的聚合物聚乙二醇,因此被称为“聚合物连接的二聚体”(PLD)。描述了包含两个鸟苷3',5'环状单磷酸酯(cGMP)部分的示例性PLD,其在激活环状核​​苷酸门控(CNG)通道和蛋白激酶方面的效力比cGMP高1000倍。每种蛋白质对具有不同平均聚合物长度的PLD均具有最佳响应,表明每种蛋白质具有独特的结合位点间距。由于最佳配体是根据经验选择的,因此多价束缚配体策略可在无需有关目标蛋白的现有结构信息的情况下鉴定出高效且特异的试剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号